Goldman Sachs’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,582
Closed -$198K 6680
2026
Q1
$198K Buy
+14,582
New +$219K ﹤0.01% 6085
2024
Q1
Sell
-149,496
Closed -$2.41M 5625
2023
Q4
$2.41M Sell
149,496
-11,063
-7% -$169K ﹤0.01% 3774
2023
Q3
$2.37M Buy
+160,559
New +$2.47M ﹤0.01% 3636

Other funds holding ECAT

Goldman Sachs's ECAT Position: Q2 2026 in Review

Goldman Sachs sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q2 2026, closing a stake of 14,582 shares — an estimated $198K sold.

Goldman Sachs first reported a position in ECAT in Q3 2023 and held it in 3 quarters. The position peaked at $2.41M in Q4 2023. 79 funds tracked by Wall St. Rank hold ECAT as of Q2 2026.

  • Goldman Sachs reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 14,582 BlackRock ESG Capital Allocation Term Trust shares in Q2 2026, an estimated $198K.
  • Goldman Sachs first reported a position in BlackRock ESG Capital Allocation Term Trust in Q3 2023 and held it in 3 quarters.
  • Goldman Sachs's BlackRock ESG Capital Allocation Term Trust position peaked at $2.41M in Q4 2023.
  • 79 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.